首页 | 本学科首页   官方微博 | 高级检索  
检索        

人参皂苷Rg3对小鼠肝癌血管形成的影响
引用本文:马英,李玉苓,孔丽.人参皂苷Rg3对小鼠肝癌血管形成的影响[J].中西医结合肝病杂志,2014(1):41-42,46,I0001.
作者姓名:马英  李玉苓  孔丽
作者单位:[1]沧州市传染病医院肝病三科河北沧州061000 [2]河北医科大学附属第三医院
基金项目:河北科技支撑计划项目(No.1213124zd)
摘    要:目的:探讨人参皂苷Rg3抑制人肝癌组织血管生成的机制。方法:①选用昆明种小鼠6只(雌雄各半,供传代用),昆明种小鼠140只(雌雄各半)按体重随机分为正常对照组(20只),肝癌模型组(30只),人参皂苷R船组(30只),5-FU(5-氟尿嘧啶)组(30只),人参皂苷Rg3联合5-FU组(30只)。采用小鼠肝癌细胞株H22肝内注射建立小鼠移植性肝癌模型的方法,将小鼠肝癌细胞株H22肝内注射24h后,人参皂苷Rg3组小鼠灌胃给药,5-FU组腹腔内注射给药,人参皂苷Rg3联合5-FU组小鼠灌胃和腹腔内注射给药,连续10d后处死各组全部小鼠并留取标本进行检测。②免疫组织化学染色观察各组小鼠肝组织血管内皮生长因子(VEGF)的表达。结果:5-FU组、人参皂苷Rg2组、人参皂苷Rg3联合5-FU组小鼠肝癌组织VEGF表达水平均低于肝癌模型组(均P〈0.05);人参皂苷Rg3组和人参皂苷Rg3联合5-FU纽小鼠肝癌组织VEGF表达水平均低于5-FU组(均P〈0.05);人参皂苷Rg3联合5-FU组小鼠肝癌组织VEGF表达水平与人参皂苷Rg3组比较,差异无显著性意义(P〉0.05)。结论:人参皂苷Rg3可抑制肝癌细胞血管生成,其可能机制是抑制VEGF表达。

关 键 词:肝癌  人参皂苷Rg3  药理作用  血管内皮生长因子  小鼠

Effect of ginsenoside Rg3 on expression of VEGF in mice with hepatocellular carcinoma
Institution:MA Ying, LI Yu-ling , KONC Li( The infectious Disease Hospital of Cangzhou City (Cangzhou Hebei, 061000) China)
Abstract:Objective: To study the effect of ginsengoside Rg3on the expression of VEGF in hepatocellular carcinoma in mice. Methods: ①One hundred-forty mouse of kunming species, with equal ratio of male andfemale, according to weight, were randomly divided into 5groups: normal control group (20), HCC model group (30), 5-FU group (30), ginseno side Rg3group (30), ginsenoside Rg3 combined with 5-FU (30). H22 cells were injected to liver tissue to form transplanted HCC model in mice. After 24 hours of injection, ginsenoside Rg3 group was orally injectedinto the stomach for administration, 5-FU group was administrated by intraperitoneal injection, ginsenoside Rg3 combined with 5-FU group was orally injected into the stomach andperitonealfor administration. After 10 days of administration, all mouse were killed and collected liver tissues for de- tection. ②The expression of VEGF in liver tissues was observed by immuno-histochemical. Results : The expression of VEGF of hepatic tissues of normal control group was significantly lower than HCC tissues of HCC model group ( P 〈 0. 05) ; the expression of VEGF of HCC tissues of 5-FU group , ginsenoside Rg3 group and ginsenoside Rg3 combined with 5-FU group were all lower than HCC model group (P 〈 0. 05 ) ; the expression of VEGF of HCC tissues of ginsenoside Rg3 combined with 5-FU group was lower than 5-FU group ( P 〈 0. 05 ) ; the expression of VEGF of HCC tissues of ginsenoside Rg3 group was lower than 5-FU group ( P 〈0. 05 ) ; In expression of VEGF of HCC tissues, there was no significant difference between gillsenoside Rg3 group and gin- senoside Rg3 combined with 5-FU group (P 〉 0. 05 ) . Conclusion: Ginsengoside Rg3 can inhibit angiogenesis of HCC , the mechanisn may be inhibit the expression of VEGF.
Keywords:liver cancer  ginsengoside Rg3/pharmacological effect  vascularendothefium growthfactor  mice
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号